Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

28.54
+0.16000.56%
Post-market: 28.620.0820+0.29%19:59 EDT
Volume:5.41M
Turnover:154.84M
Market Cap:3.60B
PE:-6.11
High:29.06
Open:28.39
Low:28.12
Close:28.38
52wk High:43.15
52wk Low:25.77
Shares:126.00M
Float Shares:123.00M
Volume Ratio:0.81
T/O Rate:4.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:8.81
PE(LYR):-8.94

Loading ...

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)

TIPRANKS
·
Sep 22

Viking Therapeutics Phase 1 data ‘highly encouraging,’ says H.C. Wainwright

TIPRANKS
·
Sep 22

Viking Therapeutics obesity data ‘very positive,’ says Morgan Stanley

TIPRANKS
·
Sep 22

Viking Therapeutics Maintains Buy Rating as VK2735 Data De-Risk Obesity Strategy; $83 Price Target Reaffirmed

TIPRANKS
·
Sep 22

Sandisk, GameStop, Viking Therapeutics, Vicor, on Holding, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 22

Viking Therapeutics obesity data ‘best-case scenario,’ says Truist

TIPRANKS
·
Sep 22

Under the Rader: Viking Stock Gains on Weight-Loss Study

Dow Jones
·
Sep 22

Viking Therapeutics rises 32.5%

TIPRANKS
·
Sep 22

Movement Alert|Viking Therapeutics Rises 34.37% in Regular Trading, Obesity Drug Maintains 97% Weight Loss Under Reduced Dosing Frequency

Market Focus
·
Sep 22

Why Is Viking Therapeutics Stock (VKTX) Up 32% Today?

TIPRANKS
·
Sep 22

Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire

Dow Jones
·
Sep 22

Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss

Stock News
·
Sep 22

Sector Update: Healthcare

MT Newswires Live
·
Sep 22

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

Dow Jones
·
Sep 22

Viking Therapeutics Says Obesity Drug Showed 'Superior' Results in Study; Shares Jump

MT Newswires Live
·
Sep 22

Viking Therapeutics Reports Strong Obesity Drug Maintenance Data

TIPRANKS
·
Sep 22

Viking Therapeutics Shares Rise 38% Premarket After Experimental Drug Maintains Weight Loss in Study

THOMSON REUTERS
·
Sep 22

Viking Therapeutics' Obesity Drug Shows 22% Weight Loss in Study

Reuters
·
Sep 22

Viking Therapeutics reports ‘positive’ results from maintenance study of VK2735

TIPRANKS
·
Sep 22

Viking Therapeutics Reports Vk2735 Maintenance Trial Keeps up to 97% of Weight Loss with Every-Other-Week Dosing

Reuters
·
Sep 22